CHEK2-related cancer predisposition

MONDO:0700271

Hereditary cancer predisposition due to variation(s) in the CHEK2 gene. Pathogenic germline variation in CHEK2 confers an autosomal dominant predisposition to tumor formation at multiple primary sites, including breast cancer and prostate cancer.

39 clinical trials for this condition and its sub-types, 7 tagged with CHEK2-related cancer predisposition itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →
Sort by